New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: Basel [u.a.] Karger 1996
Schriftenreihe:Developments in biological standardization 87
Schlagworte:
Online-Zugang:Inhaltsverzeichnis
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 cb4500
001 BV010937795
003 DE-604
005 20210702
007 t|
008 960902s1996 gw d||| |||| 10||| eng d
016 7 |a 948321539  |2 DE-101 
020 |a 3805563094  |c kart. : DM 383.00  |9 3-8055-6309-4 
035 |a (OCoLC)312417634 
035 |a (DE-599)BVBBV010937795 
040 |a DE-604  |b ger  |e rakddb 
041 0 |a eng 
044 |a gw  |c DE 
049 |a DE-12  |a DE-355  |a DE-11 
084 |a XD 3300  |0 (DE-625)152554:12905  |2 rvk 
084 |a XD 3305  |0 (DE-625)152554:12911  |2 rvk 
245 1 0 |a New approaches to stabilisation of vaccines potency  |b proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables  |c vol. ed. Fred Brown ... 
264 1 |a Basel [u.a.]  |b Karger  |c 1996 
300 |a XI, 356 S.  |b graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 1 |a Developments in biological standardization  |v 87 
500 |a Literaturangaben 
650 0 7 |a Biologische Standardisierung  |0 (DE-588)4336303-9  |2 gnd  |9 rswk-swf 
650 0 7 |a Stabilisierung  |0 (DE-588)4357300-9  |2 gnd  |9 rswk-swf 
650 0 7 |a Impfstoff  |0 (DE-588)4026655-2  |2 gnd  |9 rswk-swf 
650 0 7 |a Haltbarkeit  |0 (DE-588)4220913-4  |2 gnd  |9 rswk-swf 
650 0 7 |a Arzneimittelstabilität  |0 (DE-588)4122835-2  |2 gnd  |9 rswk-swf 
655 7 |0 (DE-588)1071861417  |a Konferenzschrift  |y 1993  |z Genf  |2 gnd-content 
655 7 |0 (DE-588)1071861417  |a Konferenzschrift  |y 1995  |z Genf  |2 gnd-content 
689 0 0 |a Impfstoff  |0 (DE-588)4026655-2  |D s 
689 0 1 |a Stabilisierung  |0 (DE-588)4357300-9  |D s 
689 0 2 |a Biologische Standardisierung  |0 (DE-588)4336303-9  |D s 
689 0 |5 DE-604 
689 1 0 |a Impfstoff  |0 (DE-588)4026655-2  |D s 
689 1 1 |a Haltbarkeit  |0 (DE-588)4220913-4  |D s 
689 1 |5 DE-604 
689 2 0 |a Impfstoff  |0 (DE-588)4026655-2  |D s 
689 2 1 |a Arzneimittelstabilität  |0 (DE-588)4122835-2  |D s 
689 2 |5 DE-604 
700 1 |a Brown, Fred  |d 1925-2004  |e Sonstige  |0 (DE-588)171991923  |4 oth 
830 0 |a Developments in biological standardization  |v 87  |w (DE-604)BV000000884  |9 87 
856 4 2 |m GBV Datenaustausch  |q application/pdf  |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007316551&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA  |3 Inhaltsverzeichnis 
943 1 |a oai:aleph.bib-bvb.de:BVB01-007316551 

Datensatz im Suchindex

DE-BY-UBR_call_number 00/XD 3305 D489
DE-BY-UBR_katkey 2250438
DE-BY-UBR_location 00
DE-BY-UBR_media_number 069009484569
_version_ 1822712273648484352
adam_text JL1S5- NEW APPROACHES TO STABILISATION OF VACCINES POTENCY WHO HEADQUARTERS, GENEVA MAY 29-31, 1995 VOLUME EDITOR FRED BROWN PLUM ISLAND ANIMAL DISEASE CENTER GREENPORT NY, USA PROCEEDINGS OF A SYMPOSIUM ORGANIZED BY THE WORLD HEALTH ORGANIZATION AND THE INTERNATIONAL ASSOCIATION OF BIOLOGICAL STANDARDIZATION (IABS TASK FORCE ON VACCINES) 57 FIGURES AND 80 TABLES, 1996 T A I) F C I) BASEL FREIL3UR 8 PARIS LONDON * NEW YORK * L / LVVJ C IV NEW DELHI * BANGKOK * SINGAPORE * TOKYO * SYDNEY CONTENTS KEYNOTE ADDRESS.. J.W. LEE SESSION I CURRENT REQUIREMENTS AND STRATEGIES FOR VACCINE STABILISATION 7 CHAIRMEN: F. HORAUD, J.W. LEE AND F. ANDRE VACCINE TRANSPORT AND STORAGE: ENVIRONMENTAL CHALLENGES 9 M. ZAFFRAN VACCINE STABILITY IN THE CONTEXT OF VACCINE DELIVERY IN A DEVELOPING COUNTRY: INDIA 19 T.J. JOHN PROBLEMS ENCOUNTERED IN THE DELIVERY AND STORAGE OF OPV IN AN AFRICAN COUNTRY 27 B.D. SCHOUB, N.A. CAMERON EXPERIENCE WITH VETERINARY VACCINES IN WARM CLIMATES 33 /./. TULASNE, P. C. LEFEVRE, J. BLANCOU SESSION II FUTURE NEEDS: WILL STABILITY REMAIN AN ISSUE FOR 21ST CENTURY VACCINES? 43 CHAIRMEN: J. JOHN AND P.D. MINOR RESEARCH PRIORITIES FOR THE WHO GLOBAL PROGRAMME FOR VACCINES AND IMMUNIZATION 45 P.-H. LAMBERT RECENT DEVELOPMENTS IN THE DESIGN OF VIRAL VACCINES 51 P.D. MINOR RECENT TRENDS IN THE DEVELOPMENTS OF BACTERIAL VACCINES 59 A.A. LINDBERG, S. PILLAI PROGRESS ON VACCINES AGAINST PARASITES 73 H.D. ENGERS, R. BERGQUIST, F. MODABBER DEVELOPMENTS IN IMMUNIZATION PRACTICES AND STRATEGIES: IMPLICATIONS FOR VACCINE STABILITY 85 S.A. PLOTKIN, M.A. FLETCHER SESSION III REASONS FOR INSTABILITY OF EXISTING VACCINES 95 CHAIRMEN: F. BROWN AND M.H. V. V. REGENMORTEL FACTORS AFFECTING THE STABILITY OF VIRAL VACCINES 97 /. PEETERMANS STABILISING ORAL POLIOVACCINE AT HIGH AMBIENT TEMPERATURES 103 J.F.E. NEWMAN, S. TIRRELL, C. ULLMAN, P.G. PIATTI, F. BROWN REASONS FOR INSTABILITY OF BACTERIAL VACCINES 113 M.J. CORBEL THE REACTION OF BACTERIAL TOXINS WITH FORMALDEHYDE AND ITS USE FOR ANTIGEN STABILIZATION 125 J. PETRE, M. PIZZA, L. NENCIONI, A. PODDA, M. T. DE MAGISTRIS, R. RAPPUOLI IX ANALYSIS OF VACCINE STABILITY 135 D.B. VOLKIN, C.J. BURKE, G. SANYAL, C.R. MIDDAUGH PHYSICOCHEMICAL STUDIES OF THE STRUCTURE AND STABILITY OF POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES 143 C. JONES, D.T. CRANE, X. LEMERCINIER, B. BOLGIANO, S.E. YOST SESSION IV NEW APPROACHES TO VACCINE STABILISATION (1) 153 CHAIRMAN: J.L. MELNICK THERMOSTABILITY OF POLIOVIRUS AND MEASLES VACCINES 155 J.L. MELNICK THE REPLACEMENT OF WATER WITH DEUTERIUM OXIDE SIGNIFICANTLY IMPROVES THE THERMAL STABILITY OF THE ORAL POLIOVIRUS VACCINE 161 R. CRAINIC, R. WU, D. OTELEA, M. M. GEORGESCU, F. DELPEYROUX, S. GUILLOT, J. BALANANT, M. TARDY-PANIT A VARICELLA VACCINE STABLE AT 5C 167 B. FANGET, A. FRANCON STABILISATION OF POLIOVIRUS WITH PIRODAVIR 173 B. ROMBAUT, K. ANDRIES, A. BOEYE REGULATORY CONSIDERATIONS FOR NEW STABILISED POLIOVACCINES 181 J.B. MILSTIEN, S. LEMON SESSION V NEW APPROACHES TO VACCINE STABILISATION (2) 191 CHAIRMEN: 5. PLOTKIN AND P.-H. LAMBERT STABILISATION OF VACCINES USING TREHALOSE (Q-T4) TECHNOLOGY 193 E.M. GRIBBON, S.D. SEN, B.J. ROSER, J. KAMPINGA POTENTIAL OF CHIMAERIC PLANT VIRUS PARTICLES AS NOVEL, STABLE VACCINES 201 F. XU, T.D. JONES, P.B. RODGERS PROTEIN STABILISATION USING ADDITIVES BASED ON MULTIPLE ELECTROSTATIC INTERACTIONS 207 T.D. GIBSON STABILITY OF YELLOW FEVER VACCINE 219 T.P. MONATH SESSION VI POSTER SESSION 227 CHAIRMAN: D.I. MAGRATH VACCINE STABILITY NOT BY ELIMINATING THERMOLABILITY BUT THROUGH THE ENVIRONMENTAL STABILITY (ABSTRACT) 229 S.C. ARYA BIODEGRADABLE MICROPARTICLES AS PARENTERAL VACCINE DELIVERY SYSTEMS (ABSTRACT) 231 A.G.A. COOMBES, E.C. LAVELLE, P.G. JENKINS, J. HOLLAND, S.S. DAVIS SESSION VII NEW APPROACHES TO VACCINE STABILISATION (3) 233 CHAIRMEN: M.J. CORBEL AND R. CRAINIC STABILIZATION OF RINDERPEST VACCINE BY MODIFICATION OF THE LYOPHILIZATION PROCESS 235 J.A. HOUSE, J.C. MARINER CONTENTS STABILITY OF RECOMBINANT VACCINIA-RABIES VACCINE IN VETERINARY USE 245 P.P. PASTORET, B. BROCHIER, B. LANGUET, C. DURET, G. CHAPPUIS, P. DESMETTRE STABILISATION OF BCG VACCINES 251 M. GHEORGHIU, M. LAGRANDERIE, A.M. BALAZUC STABILITY TESTING IN HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINES 263 B. KLUG GLYCOCONJUGATE VACCINES: FUTURE COMBINATIONS 269 P.R. PARADISO, A.A. LINDBERG FACTORS INFLUENCING THE STABILITY OF LIVE ORAL ATTENUATED BACTERIAL VACCINES 277 S.J. CRYZ JR., O. PASTERIS, SJ. VARALLYAY, E. FIIRER MIMICRY OF VIRAL EPITOPES WITH RETRO-INVERSO PEPTIDES OF INCREASED STABILITY 283 N. BENKIRANE, G. GUICHARD, J.P. BRIAND, S. MULLER, F. BROWN, M.H.V. VAN REGENMORTEL STRATEGIES FOR STABILIZING TETANUS TOXOID TOWARDS THE DEVELOPMENT OF A SINGLE-DOSE TETANUS VACCINE 293 S.P. SCHWENDEMAN, H.R.COSTANTINO, R.K. GUPTA, M. TOBIO, A.-C. CHANG, M.J. ALONSO, G.R. SIBER, R. LANGER SESSION VIII STANDARDIZATION OF VACCINE STABILITY: REGULATORY ISSUES 307 CHAIRMEN: E. GRIFFITHS AND M. HAASE STABILITY TESTING REQUIREMENTS FOR VACCINES - DRAFT GUIDELINES OF THE INTERNATIONAL CONFE- RENCE ON HARMONIZATION (ICH) 309 M. HAASE REGULATORY REQUIREMENTS FOR VETERINARY VACCINE STABILITY IN THE EUROPEAN COMMUNITY 319 D. FAWTHROP REGULATORY PRACTICES AND PROBLEMS WITH VACCINE STABILITY STUDIES AND THE ESTABLISHMENT OF SHELF LIVES 329 A. FENYVES GENERAL DISCUSSION 335 D.I. MAGRATH SESSION IX SUMMARY AND CONCLUSIONS 337 CHAIRMEN: G.C. SCHILD AND F. HORAUD CONTENTS XI
any_adam_object 1
author_GND (DE-588)171991923
building Verbundindex
bvnumber BV010937795
classification_rvk XD 3300
XD 3305
ctrlnum (OCoLC)312417634
(DE-599)BVBBV010937795
discipline Medizin
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02401nam a2200553 cb4500</leader><controlfield tag="001">BV010937795</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210702 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">960902s1996 gw d||| |||| 10||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">948321539</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805563094</subfield><subfield code="c">kart. : DM 383.00</subfield><subfield code="9">3-8055-6309-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)312417634</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010937795</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3300</subfield><subfield code="0">(DE-625)152554:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3305</subfield><subfield code="0">(DE-625)152554:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New approaches to stabilisation of vaccines potency</subfield><subfield code="b">proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables</subfield><subfield code="c">vol. ed. Fred Brown ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 356 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Developments in biological standardization</subfield><subfield code="v">87</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biologische Standardisierung</subfield><subfield code="0">(DE-588)4336303-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Stabilisierung</subfield><subfield code="0">(DE-588)4357300-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Haltbarkeit</subfield><subfield code="0">(DE-588)4220913-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelstabilität</subfield><subfield code="0">(DE-588)4122835-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1993</subfield><subfield code="z">Genf</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1995</subfield><subfield code="z">Genf</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Stabilisierung</subfield><subfield code="0">(DE-588)4357300-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Biologische Standardisierung</subfield><subfield code="0">(DE-588)4336303-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Haltbarkeit</subfield><subfield code="0">(DE-588)4220913-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Arzneimittelstabilität</subfield><subfield code="0">(DE-588)4122835-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brown, Fred</subfield><subfield code="d">1925-2004</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)171991923</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Developments in biological standardization</subfield><subfield code="v">87</subfield><subfield code="w">(DE-604)BV000000884</subfield><subfield code="9">87</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&amp;doc_library=BVB01&amp;local_base=BVB01&amp;doc_number=007316551&amp;sequence=000001&amp;line_number=0001&amp;func_code=DB_RECORDS&amp;service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007316551</subfield></datafield></record></collection>
genre (DE-588)1071861417 Konferenzschrift 1993 Genf gnd-content
(DE-588)1071861417 Konferenzschrift 1995 Genf gnd-content
genre_facet Konferenzschrift 1993 Genf
Konferenzschrift 1995 Genf
id DE-604.BV010937795
illustrated Illustrated
indexdate 2024-12-23T14:17:37Z
institution BVB
isbn 3805563094
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-007316551
oclc_num 312417634
open_access_boolean
owner DE-12
DE-355
DE-BY-UBR
DE-11
owner_facet DE-12
DE-355
DE-BY-UBR
DE-11
physical XI, 356 S. graph. Darst.
publishDate 1996
publishDateSearch 1996
publishDateSort 1996
publisher Karger
record_format marc
series Developments in biological standardization
series2 Developments in biological standardization
spellingShingle New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables
Developments in biological standardization
Biologische Standardisierung (DE-588)4336303-9 gnd
Stabilisierung (DE-588)4357300-9 gnd
Impfstoff (DE-588)4026655-2 gnd
Haltbarkeit (DE-588)4220913-4 gnd
Arzneimittelstabilität (DE-588)4122835-2 gnd
subject_GND (DE-588)4336303-9
(DE-588)4357300-9
(DE-588)4026655-2
(DE-588)4220913-4
(DE-588)4122835-2
(DE-588)1071861417
title New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables
title_auth New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables
title_exact_search New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables
title_full New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables vol. ed. Fred Brown ...
title_fullStr New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables vol. ed. Fred Brown ...
title_full_unstemmed New approaches to stabilisation of vaccines potency proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables vol. ed. Fred Brown ...
title_short New approaches to stabilisation of vaccines potency
title_sort new approaches to stabilisation of vaccines potency proceedings of a symposium who headquarters geneva may 29 31 1995 80 tables
title_sub proceedings of a symposium, WHO Headquarters, Geneva, May 29 - 31, 1995 ; 80 tables
topic Biologische Standardisierung (DE-588)4336303-9 gnd
Stabilisierung (DE-588)4357300-9 gnd
Impfstoff (DE-588)4026655-2 gnd
Haltbarkeit (DE-588)4220913-4 gnd
Arzneimittelstabilität (DE-588)4122835-2 gnd
topic_facet Biologische Standardisierung
Stabilisierung
Impfstoff
Haltbarkeit
Arzneimittelstabilität
Konferenzschrift 1993 Genf
Konferenzschrift 1995 Genf
url http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007316551&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
volume_link (DE-604)BV000000884
work_keys_str_mv AT brownfred newapproachestostabilisationofvaccinespotencyproceedingsofasymposiumwhoheadquartersgenevamay2931199580tables